Chief Executive Officer
CurrentWe launched the Octomera business unit officially in July 2023 to focus in on growing our advanced therapeutics supply and decentralized autologous GMP services and support. Octomera operates with an agnostic, flexible facilities model to bring lifesaving medicines to patients at the point of care with proprietary Octomera Processing Units & Labs (OMPULs)..